These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 19175545

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P, Hervig T, Isola H, Wiesel ML, Kientz D, Pinkoski L, Singh Y, Lin L, Corash L, Cazenave JP.
    Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
    Lozano M, Galan A, Mazzara R, Corash L, Escolar G.
    Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of bacterial inactivation in prestorage pooled, leukoreduced, whole blood-derived platelet concentrates suspended in plasma prepared with photochemical treatment.
    Brecher ME, Hay S, Corash L, Hsu J, Lin L.
    Transfusion; 2007 Oct; 47(10):1896-901. PubMed ID: 17880617
    [Abstract] [Full Text] [Related]

  • 30. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R, Fröhlich A, Mayaudon V, Lin L.
    J Clin Apher; 2004 Oct; 19(4):185-91. PubMed ID: 15597347
    [Abstract] [Full Text] [Related]

  • 31. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion.
    Rasonglès P, Angelini-Tibert MF, Simon P, Currie C, Isola H, Kientz D, Slaedts M, Jacquet M, Sundin D, Lin L, Corash L, Cazenave JP.
    Transfusion; 2009 Jun; 49(6):1083-91. PubMed ID: 19309473
    [Abstract] [Full Text] [Related]

  • 32. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.
    Knutson F, Osselaer J, Pierelli L, Lozano M, Cid J, Tardivel R, Garraud O, Hervig T, Domanovic D, Cukjati M, Gudmundson S, Hjalmarsdottir IB, Castrillo A, Gonzalez R, Brihante D, Santos M, Schlenke P, Elliott A, Lin JS, Tappe D, Stassinopoulos A, Green J, Corash L.
    Vox Sang; 2015 Nov; 109(4):343-52. PubMed ID: 25981525
    [Abstract] [Full Text] [Related]

  • 33. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment.
    Cognasse F, Osselaer JC, Payrat JM, Chavarin P, Corash L, Garraud O.
    Transfusion; 2008 May; 48(5):809-13. PubMed ID: 18298593
    [Abstract] [Full Text] [Related]

  • 34. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP, Infanti L, Studt JD, Martinez M, Stern M, Gratwohl A, Passweg J, Tichelli A, Buser AS.
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment.
    North A, Ciaravino V, Mufti N, Corash L.
    Transfusion; 2011 Oct; 51(10):2208-18. PubMed ID: 21985050
    [Abstract] [Full Text] [Related]

  • 37. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light.
    Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L.
    Transfusion; 2005 Apr; 45(4):580-90. PubMed ID: 15819680
    [Abstract] [Full Text] [Related]

  • 38. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
    Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG.
    Transfusion; 2006 Oct; 46(10):1693-704. PubMed ID: 17002625
    [Abstract] [Full Text] [Related]

  • 39. Effect of extending the platelet storage time on platelet utilization: predictions from a mathematical model of prophylactic platelet support.
    Pereira A, Sanz C.
    Transfus Med; 2007 Apr; 17(2):119-27. PubMed ID: 17430468
    [Abstract] [Full Text] [Related]

  • 40. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets.
    Bruchmüller I, Lösel R, Bugert P, Corash L, Lin L, Klüter H, Janetzko K.
    Platelets; 2005 Dec; 16(8):441-5. PubMed ID: 16287610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.